Singapore scientists develop 'potentially game-changing' saliva antigen rapid test

Singapore scientists develop 'potentially game-changing' saliva antigen rapid test

Antigen Rapid Test, Covid-19

8/12/2021 2:56:00 PM

Singapore scientists develop 'potentially game-changing' saliva antigen rapid test

SINGAPORE — A simpler, less invasive way to test for Covid-19 quickly that is close to the accuracy of a polymerase chain reaction (PCR) test in terms of correctly identifying infected individuals has been developed by scientists in Singapore.

Unlike other saliva tests that must be done first thing in the morning after an extended period of fasting, the test can be used at any time of the day, the scientists said at a media conference on Wednesday (Dec 8).They said the test, which can be self-administered and is anticipated to have a low cost, had outperformed existing antigen rapid tests (ARTs) in early clinical testing and is"potentially game-changing".

The announcement by the team, comprising researchers from Duke-NUS Medical School, Singapore General Hospital (SGH) and National Cancer Centre Singapore (NCCS), and the National University of Singapore, comes two days after their findings were published in a peer-reviewed scientific journal.

The Parallel Amplified Saliva Rapid Point-of-care Test (Pasport) is, however, still perhaps three to six months away from being commercially available, the team said.Dr Jenny Low, a senior consultant with the Department of Infectious Diseases at SGH, said there is still a need to carry out a “couple more clinical studies to validate the final commercial product”.

Micron to shut DRAM chip design operations in Shanghai - SCMP

When asked if it will be able to detect the new Omicron variant, Associate Professor Melvin Chua, a clinician-scientist at the NCCS, responded that the team “does not see it as an issue”.In any case, Duke-NUS and SingHealth have filed intellectual property protection for the invention, and are currently in talks with interested parties for licensing.

However, Dr Soo Khee Chee, a Benjamin Sheares Professor in Academic Medicine at the SingHealth Duke-NUS Oncology Academic Clinical Programme, said the team has yet to receive approval for use from the Health Sciences Authority, though they are hoping to meet with the authority shortly.

When it does become available, the researchers said that it will likely take about 15 minutes for the user to obtain their test result.In terms of cost, Dr Soo said he expects it to be similar to other test kits available on the market, but “vastly superior”.

Wanted: Volunteers to catch COVID in the name of science

HOW DOES IT COMPARE?The team’s clinical trials involved more than 100 participants between May and August this year.According to their research, published on Monday in the journal Microchimica Acta, the trials found that Pasport’s sensitivityin detecting the virus was 97 per cent and its specificity, 90.6 per cent, compared to PCR tests.

Sensitivity refers to the ability of the test to correctly identify patients that have the disease, while specificity refers to the ability to correctly identify patients that do not.The Ministry of Health said on its website that the PCR test — often referred to as the gold standard for diagnosing Covid-19 — has a sensitivity and specificity percentage of 99.5 per cent and 100 per cent respectively.

The scientists said it was not meaningful to compare the sensitivity and specificity levels of their invention with regular ARTs as they were citing their percentages in relation to PCR tests and not in absolute terms.Up until now, saliva tests have not been rolled out on a large scale to detect the coronavirus as they were not considered reliable enough, said the researchers.

Western banks flag concerns over China's draft offshore listing rules

Pasport’s lead inventor, Dr Danny Tng, a medical officer at the Department of Infectious Diseases at SGH, said this is because the concentration of viral particles in saliva drops steeply after an individual eats or drinks.This means that conventional saliva antigen tests are usually only reliable when they are performed first thing in the morning, after an overnight fast and before breakfast or brushing teeth.

And while there are more accurate saliva PCR tests, they have their drawbacks too, said the researchers.PCR tests not only require trained personnel and laboratory infrastructure, but they also take about 24 hours before the results are known, said Dr Low.

As for swab-based ARTs, Dr Soo said that while they can be self-administered, it is not “the most pleasant experience”.Moreover, as it tends to elicit a sneeze, he said it puts a swabber at risk of potential infection if they are administering it to someone else.

HOW IT WORKSA solution was devised by the researchers to overcome the challenges of using saliva for rapid testing in the form of a two-stage process.While Pasport uses nanoparticles to bind the virus like other ARTs, it also adds a second type of nanoparticle, said Dr Tng.

This has the effect of binding the first set of nanoparticles to “amplify the signal”, which increases Pasport’s accuracy in detecting the virus.Furthermore, it also allows saliva testing to be used at any time of the day because its sensitivity is not compromised even after eating or drinking.

In terms of how it is used, Dr Tng demonstrated that the user only needs to put their drool into a receptacle, and then use a pipette to extract the saliva and transfer it to two sample wells on the test kit.EARLY DIAGNOSISDr Tng said testing is an indispensable tool in the management of Covid-19 cases.

“A reliable and painless saliva antigen test that is affordable and convenient to perform would encourage more to be tested, and more frequent testing,” he said.Turning to Pasport’s potential applications, the researchers said that apart from serving as screening tool for travellers at the airport or attendees of large scale events, there could be other useful contributions for managing Covid-19 cases here.

Professor Ooi Eng Eong, from the Duke-NUS Emerging Infectious Diseases Programme, said it could be used in conjunction with administering antiviral drugs.The Reuters news agency reportedon Oct 7thatpharmaceutical company Merck had announced a supply and purchase agreement with Singapore that will ensure access to its experimental oral Covid-19 antiviral drug.

The drug Molnupiravir is designed to introduce errors into the genetic code of the coronavirus and would be the first oral antiviral medication for Covid-19.“Like any other antiviral drug, the earlier you give it in the course of infection, the better the results. If you delay two to three days, then you're effectively losing the potency of what the antiviral drug can do,” said Prof Ooi.

As Pasport is as “good as a PCR test”, he said that it will enable general practitioners to administer a Covid-19 test on their patient and diagnose them on the spot without having to wait for laboratory results“If we can give the drug early enough, then we're going to be able to prevent many people from going on to develop severe Covid,” said Prof Ooi.

Read more: TODAY »

Saliva will be a kinder media than the swab. Less phobia in use. can be more accurate than ordinary SWAB if it is workable to detect Covid from saliva. In SWAB, unless one goes around deeper into the nostril; otherwise, the reading might not be accurate. Less profitable now. More and more companies are doing away with ART for those fully vaccinated. But sure is still useful.

新加坡科学家开发出“可能改变游戏规则”的唾液抗原快速检测 ??

Singapore scientists develop 'potentially game-changing' saliva-based antigen rapid testSINGAPORE — A simpler, less invasive way to test for Covid-19 quickly that is close to the accuracy of a polymerase chain reaction (PCR) test in terms of correctly identifying infected individuals has been developed by scientists in Singapore. then please let the children and elderly use it asap.

Nearly 70 medics at Spanish hospital catch Covid after Christmas partyPeople who were infected all had antigen tests or third booster jabs before the party

Viagra could be a potent force in the fight against Alzheimer’s, says studyA new study revealed that Viagra may be effective at targeting some proteins involved in the development of Alzheimer’s in the brain.

University of Hong Kong researchers develop COVID killing steelThe new metal also kills the H1N1 influenza A virus (the virus strain behind swine flu) and E. coli bacteria.

Where did the coronavirus omicron variant come from? Scientists suggest it evolved in one person.When someone with a weakened immune system tries to control the SARS-CoV-2 virus, it can shape-shift to avoid its own destruction.

Skills in digital, green and care sectors expected to be in demand: SkillsFuture reportSINGAPORE — There is a rising number of job opportunities in the digital, green and care economies, based on an inaugural yearly report from national skills agency SkillsFuture Singapore.